Patent

NeuroVive holds global patent rights for the use of cyclosporine to protect nerve cells in cases of acute neurological injury. NeuroVive also holds exclusive rights to patent rights to a cyclosporine-A-based lipid emulsion.

Geographical scope of patent portfolio